(3S)-8-[6-amino-5-[[2-(trifluoromethyl)-3-pyridinyl]sulfanyl]pyrazin-2-yl]-8-azaspiro[4.5]decan-3-ol
C19H22F3N5OS — CID 139365342
Data last refreshed: (MolForge compound catalog, from PubChem)
About (3S)-8-[6-amino-5-[[2-(trifluoromethyl)-3-pyridinyl]sulfanyl]pyrazin-2-yl]-8-azaspiro[4.5]decan-3-ol
(3S)-8-[6-amino-5-[[2-(trifluoromethyl)-3-pyridinyl]sulfanyl]pyrazin-2-yl]-8-azaspiro[4.5]decan-3-ol (PubChem CID 139365342) has the molecular formula C19H22F3N5OS and a molecular weight of 425.48 g/mol. Its IUPAC name is (3S)-8-[6-amino-5-[[2-(trifluoromethyl)-3-pyridinyl]sulfanyl]pyrazin-2-yl]-8-azaspiro[4.5]decan-3-ol.
Molecular Properties
| Compound Name | (3S)-8-[6-amino-5-[[2-(trifluoromethyl)-3-pyridinyl]sulfanyl]pyrazin-2-yl]-8-azaspiro[4.5]decan-3-ol |
|---|---|
| PubChem CID | 139365342 |
| Molecular Formula | C19H22F3N5OS |
| Molecular Weight | 425.48 g/mol |
| Exact Mass | 425.15 |
| IUPAC Name | (3S)-8-[6-amino-5-[[2-(trifluoromethyl)-3-pyridinyl]sulfanyl]pyrazin-2-yl]-8-azaspiro[4.5]decan-3-ol |
| SMILES | Nc1nc(N2CCC3(CC[C@H](O)C3)CC2)cnc1Sc1cccnc1C(F)(F)F |
| InChI | InChI=1S/C19H22F3N5OS/c20-19(21,22)15-13(2-1-7-24-15)29-17-16(23)26-14(11-25-17)27-8-5-18(6-9-27)4-3-12(28)10-18/h1-2,7,11-12,28H,3-6,8-10H2,(H2,23,26)/t12-/m0/s1 |
| InChIKey | OLDOTOIWPCSTIJ-LBPRGKRZSA-N |
| XLogP | 3.76 |
| TPSA | 88.16 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 425.48 |
| LogP ≤ 5 | 3.76 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 139365342 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.